MiR-221/222 target the DNA methyltransferase MGMT in glioma cells
about
Exploring miRNA-Associated Signatures with Diagnostic Relevance in Glioblastoma Multiforme and Breast Cancer PatientsmicroRNAs and cancer metabolism reprogramming: the paradigm of metforminMicroRNA expression signatures determine prognosis and survival in glioblastoma multiforme--a systematic overview.A genome-wide miRNA screen revealed miR-603 as a MGMT-regulating miRNA in glioblastomas.Methylation of DACT2 promotes papillary thyroid cancer metastasis by activating Wnt signalingRegulation of expression of O6-methylguanine-DNA methyltransferase and the treatment of glioblastoma (Review).miR-130a can predict response to temozolomide in patients with glioblastoma multiforme, independently of O6-methylguanine-DNA methyltransferaseGenome-Wide DNA Methylation Analysis Identifies Novel Hypomethylated Non-Pericentromeric Genes with Potential Clinical Implications in ICF Syndrome.Disruption of NF-κB signaling by fluoxetine attenuates MGMT expression in glioma cells.A five-miRNA signature with prognostic and predictive value for MGMT promoter-methylated glioblastoma patientsRole of MicroRNAs in Malignant GliomamiR-340 predicts glioblastoma survival and modulates key cancer hallmarks through down-regulation of NRASLong noncoding RNA RP11-838N2.4 enhances the cytotoxic effects of temozolomide by inhibiting the functions of miR-10a in glioblastoma cell lines.Potential Value of miR-221/222 as Diagnostic, Prognostic, and Therapeutic Biomarkers for Diseases.MGMT testing--the challenges for biomarker-based glioma treatment.Contribution of microRNA analysis to characterisation of pancreatic lesions: a review.MiR-198 enhances temozolomide sensitivity in glioblastoma by targeting MGMT.Upregulation of microrna-451 increases the sensitivity of A549 cells to radiotherapy through enhancement of apoptosis.RYK promotes the stemness of glioblastoma cells via the WNT/ β-catenin pathwaySensitivity to PRIMA-1MET is associated with decreased MGMT in human glioblastoma cells and glioblastoma stem cells irrespective of p53 statusMiR-204 silencing in intraepithelial to invasive cutaneous squamous cell carcinoma progression.Mir-221/222 are promising targets for innovative anticancer therapy.miR clusters target cellular functional complexes by defining their degree of regulatory freedom.miRNA array screening reveals cooperative MGMT-regulation between miR-181d-5p and miR-409-3p in glioblastoma.MiR-221 promotes stemness of breast cancer cells by targeting DNMT3b.Gas5 Exerts Tumor-suppressive Functions in Human Glioma Cells by Targeting miR-222.Suppression of miR-221 inhibits glioma cells proliferation and invasion via targeting SEMA3B.DNA methylation in adult diffuse gliomas.Let-7f Inhibits Glioma Cell Proliferation, Migration, and Invasion by Targeting Periostin.MicroRNA-138 promotes acquired alkylator resistance in glioblastoma by targeting the Bcl-2-interacting mediator BIM.Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III.MicroRNA signatures predict prognosis of patients with glioblastoma multiforme through the Cancer Genome Atlas.Serum microRNA profiling in patients with glioblastoma: a survival analysis.MicroRNA-target cross-talks: Key players in glioblastoma multiforme.Evaluation of apoptosis induced by exposure to antineoplastic drugs in peripheral blood lymphocytes of nurses.Repair gene O6 -methylguanine-DNA methyltransferase is controlled by SP1 and up-regulated by glucocorticoids, but not by temozolomide and radiation.Predictive and Prognostic Roles of Abnormal Expression of Tissue miR-125b, miR-221, and miR-222 in Glioma.Plasma miR-221/222 Family as Novel Descriptive and Prognostic Biomarkers for Glioma.
P2860
Q26796590-578F7258-5F2F-4398-B388-AC994FDF77BFQ34357915-10FFF849-C0EE-4F11-AED6-3BA2026DD76CQ34409620-07593661-2CE1-47F8-9341-628077B7AE1EQ34427825-DF6D7BDA-9FEC-47DC-BCE2-48B68ADBAE5AQ34466347-029C76B4-0165-4871-80BB-3A7B275EA8CDQ34478948-0C4DAD37-8E44-4240-A09E-39568E56B49CQ35132876-9D955589-E1D2-44FD-8A55-8AAA5F2AE12EQ35688081-1C153D29-56BD-44E9-A2B8-A764497ED849Q35997569-F36D31AE-B0BD-452C-B2BC-6C7653BC84BEQ36557284-3F0358A2-663A-42A2-9DEF-910296A4A9D0Q36797902-BCF8C0F2-2795-4CB3-9F9A-03661AC07C85Q37190094-2373596A-4CA5-4B05-A1DB-684430332FD4Q37536715-D04D3FB9-841A-4FA8-84AA-88299DF5515EQ37643929-F4C7310B-31A2-4AF6-99AC-812C56D43A8DQ38218848-12B5BBC0-7632-4AF9-B2AD-7F40E93D03FBQ38575189-D2D563B1-76FA-42E9-86A1-C272FF71D1ABQ38692922-E0683F8F-5E8C-4085-B51F-A520D0E29149Q38704894-92C6AC8F-B796-4E9E-9690-4A0AFEDDF388Q38721422-A74B77EC-54A6-48D0-92F9-C065165C9A61Q38751430-2436D4FE-64D3-4C69-88ED-D6C857E9B46FQ38755893-801ADF34-DE86-45E3-B218-18449CA4BDB4Q38767024-162BF6D8-832E-4C95-9BC6-37EC23A0890BQ38771877-70E97500-6C3C-431E-82AD-17AD8CE3CD96Q38779883-C0AB74DF-307F-49F1-9D94-968308C21D1EQ38820308-8A37FD0E-F1A1-4EFE-ADE7-460C512FF99EQ38835306-B6CC1AD5-3BAC-43DC-B426-C4FE22319074Q38850720-26DA9746-0596-4DDE-9736-9E39622473D7Q38861997-9BA1BADD-E6FC-44D9-BAA2-B6A48A0788B5Q38904125-C6B11B99-4CA9-4B8D-A2D8-F0BA2467BAA1Q39990148-8A4B6EFB-1773-4707-800F-163A358410F8Q41135067-99588474-D43A-4CB5-87B4-2EF456C66ADCQ41709514-BD896339-1DB6-48CB-AEF4-3C57F0D38BC6Q42317085-44C44B28-8691-4A9A-AF4D-F43F00F7F462Q46190130-A8FE5812-B016-4B7E-8796-8F9AF7DEBF88Q47749421-8BB2697F-048E-44AB-84C0-5163311E08FAQ48256976-32B2BE40-BF26-44B1-A2BD-42FF5444401BQ48414232-0304C8F1-71E1-4545-ADA3-D23AECC06EA5Q53624071-E7D62F77-74AD-4191-BDBC-DD4BB03DB1A2
P2860
MiR-221/222 target the DNA methyltransferase MGMT in glioma cells
description
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique PLoS ONE
@fr
artículu científicu espublizáu en 2013
@ast
im Januar 2013 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2013/01/01)
@sk
vědecký článek publikovaný v roce 2013
@cs
wetenschappelijk artikel (gepubliceerd op 2013/01/01)
@nl
наукова стаття, опублікована в січні 2013
@uk
name
MiR-221/222 target the DNA methyltransferase MGMT in glioma cells
@ast
MiR-221/222 target the DNA methyltransferase MGMT in glioma cells
@en
MiR-221/222 target the DNA methyltransferase MGMT in glioma cells
@nl
type
label
MiR-221/222 target the DNA methyltransferase MGMT in glioma cells
@ast
MiR-221/222 target the DNA methyltransferase MGMT in glioma cells
@en
MiR-221/222 target the DNA methyltransferase MGMT in glioma cells
@nl
prefLabel
MiR-221/222 target the DNA methyltransferase MGMT in glioma cells
@ast
MiR-221/222 target the DNA methyltransferase MGMT in glioma cells
@en
MiR-221/222 target the DNA methyltransferase MGMT in glioma cells
@nl
P2093
P2860
P50
P3181
P1433
P1476
MiR-221/222 target the DNA methyltransferase MGMT in glioma cells
@en
P2093
Angel Diaz-Lagares
Cristina Quintavalle
Elvira Donnarumma
Giulia Romano
Giuseppina Roscigno
Margherita Iaboni
Pasqualino De Marinis
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0074466
P407
P577
2013-01-01T00:00:00Z